Women with chest pain and non-obstructive arteries: personalized diagnostic and treatment approach
Official title: Invasive Functional and Morphological Coronary Assessment Followed by Phenotype-Guided Multidisciplinary Treatment in Women With Angina and Non-Obstructive Coronary Arteries: A Prospective Single-Center Interventional Study
Run by Hospital de Clínicas Dr. Manuel Quintela · NCT07593157 · Data updated 2026-11-12
This study tests a personalized diagnostic-and-treatment pathway for women with angina but non-obstructive coronary arteries to see if targeted therapy improves symptoms and quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 35 Years to 75 Years |
| Sex | Women only |
| Enrollment | 50 (estimated) |
| Sponsor | Hospital de Clínicas Dr. Manuel Quintela Academic / other |
| Locations | 1 site (Montevideo, Montevideo Department) |
| Status | Recruiting |
| Started | May 15, 2026 |
| Main results expected | April 30, 2029 |
| Study ends | April 30, 2029 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT07593157 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 35–75 with stable angina or suspected ischemia and non-obstructive arteries (no stenosis ≥50%), able to undergo invasive assessment and follow-up.
✕Probably not a fit
Patients without a specific phenotype identified or those unable to adhere to the follow-up may see limited benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this single-center study, women with angina and non-obstructive coronary arteries undergo an invasive assessment that combines physiology testing, acetylcholine provocation, and intracoronary imaging to identify the dominant mechanism of angina. Based on the phenotype identified, participants receive individualized pharmacologic and lifestyle therapies, with psycho-emotional support as needed. Follow-up visits at 1, 6, and 12 months monitor angina symptoms, quality of life, exercise capacity, treatment adherence, and cardiovascular events. The goal is to establish a structured diagnostic and therapeutic pathway for ANOCA and related conditions at a Uruguayan academic center.
Why it matters
Potential benefit: If successful, the approach could lead to more accurate diagnosis and tailored treatment, potentially reducing symptoms and improving quality of life for women with ANOCA.
How similar studies have gone: Prior research supports the value of phenotype-guided management in ANOCA, but evidence is still evolving and this single-center study adds contemporary, procedure-based personalization.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female participants aged 35 to 75 years. * Symptoms compatible with stable angina or suspected myocardial ischemia. * Non-obstructive coronary arteries, defined as absence of angiographic stenosis greater than or equal to 50%. * Ability to undergo invasive coronary assessment and clinical follow-up. * Written informed consent. Exclusion Criteria: * Significant structural heart disease. * Severe left ventricular systolic dysfunction, defined as left ventricular ejection fraction \<40%. * Clinically relevant contraindication to adenosine or acetylcholine, including severe asthma, untreated high-grade atrioventricular block, or known hypersensitivity. * Active oncological disease or life expectancy less than 12 months. * Inability to complete the diagnostic or therapeutic study protocol. * Participation in another clinical study that could interfere with the present protocol.
Where it's running
-
Hospital de Clínicas Dr. Manuel Quintela
Montevideo, Montevideo Department, Uruguay Recruiting
Study contacts
- Study coordinator: Rafael Mila, MD
- Email: r1000a@gmail.com
- Phone: +59824871515
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comprehensive coronary physiology testing for adults with angina but no blocked coronary arteries in the Czech Republic
This project will test detailed invasive coronary physiology and vasospasm tests in adults who have angina but no major coronary blockages to see if microvascular dysfunction or spasms explain their symptoms.
-
Stratified medicine approach for managing angina without obstructive coronary artery disease
This study is testing if a personalized treatment plan based on a special heart test can help people with angina who don’t have blocked arteries feel better and improve their health.
-
Multi-sensor wireless pressure catheter to test microvascular function in people with angina and non-obstructive arteries
Doctors are testing a new wireless pressure catheter to see if it can accurately diagnose coronary microvascular dysfunction in people with angina but non-obstructive arteries, using MRI perfusion as the reference test.
-
How kidney transplant affects blood flow in the heart's tiny vessels in people with advanced CKD
This study will try to see if getting a kidney transplant improves blood flow in the small vessels of the heart for people with advanced chronic kidney disease who are on the transplant waitlist.
-
Polish registry of heart nerve–targeting treatments (cardioneuroablation and cardioneuromodulation)
This registry collects information to see how nerve-targeting heart procedures work for adults with fainting, abnormal heart rhythms, or orthostatic problems.
-
Nitrate Beetroot Juice to Help Blood Flow in Women with ANOCA and CMD
We’re testing whether nitrate-rich beetroot juice for 14 days can improve heart blood flow and quality of life for women with ANOCA and CMD compared with a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.